Clinical Trials · NCT00936390

Radiation Therapy With or Without Androgen-Deprivation Therapy in Treating Patients With Prostate Cancer

CompletedPhase 3Gonadorelin (Approved)
Phase
Phase 3
Recruitment status
Completed
Sponsor
Radiation Therapy Oncology Group
Enrollment
1,538
Start date
Sep 2009
Locations
518 sites, United States, Canada
Primary endpoint
Percentage of Participants Alive (Overall Survival)
View Gonadorelin compound reference